Moore, Jill E.
Pratt, Henry E.
Purcaro, Michael J.
Weng, Zhiping http://orcid.org/0000-0002-3032-7966
Funding for this research was provided by:
National Human Genome Research Institute (1U24HG009446-01, 5U41HG007000)
Article History
Received: 5 September 2019
Accepted: 23 December 2019
First Online: 22 January 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Z. Weng is a cofounder of Rgenta Therapeutics and she serves on its scientific advisory board.